Paper39182011
Assessment In vitro and In silico of the Activity of Thiadiazines as NorA Efflux Pump Inhibitors.
de Araújo ACJ and 19 others. Curr Microbiol, 2024. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Assessment In vitro and In silico of the Activity of Thiadiazines as NorA Efflux Pump Inhibitors. Papers, record 39182011. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39182011
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Assessment In vitro and In silico of the Activity of Thiadiazines as NorA Efflux Pump Inhibitors.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Bacterial Agents | Major topic |
| Staphylococcus aureus | Major topic |
| Molecular Docking Simulation | Major topic |
| Microbial Sensitivity Tests | Major topic |
| Bacterial Proteins | Major topic |
| ATP-Binding Cassette, Sub-Family C Proteins | Major topic |
| Thiadiazines | Major topic |
| Computer Simulation |
Source PubMed
References24
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34417720 | Inhibition of the MepA efflux pump by limonene demonstrated by in vitro and in silico methods. | Folia Microbiol (Praha) | 2022 | https://conductscience.org/library/papers/34417720 | PubMed |
| 2 | 36830254 | The Major Facilitator Superfamily and Antimicrobial Resistance Efflux Pumps of the ESKAPEE Pathogen Staphylococcus aureus. | Antibiotics (Basel) | 2023 | https://conductscience.org/library/papers/36830254 | PubMed |
| 3 | 25435309 | Molecular mechanisms of antibiotic resistance. | Nat Rev Microbiol | 2015 | https://conductscience.org/library/papers/25435309 | PubMed |
| 4 | 25151481 | The future of antibiotics and resistance: a tribute to a career of leadership by John Bartlett. | Clin Infect Dis | 2014 | https://conductscience.org/library/papers/25151481 | PubMed |
| 5 | 29788355 | SWISS-MODEL: homology modelling of protein structures and complexes. | Nucleic Acids Res | 2018 | https://conductscience.org/library/papers/29788355 | PubMed |
| 6 | 37649138 | Potentiating-antibiotic activity and absorption, distribution, metabolism, excretion and toxicity properties (ADMET) analysis of synthetic thiadiazines against multi-drug resistant (MDR) strains. | Fundam Clin Pharmacol | 2024 | https://conductscience.org/library/papers/37649138 | PubMed |
| 7 | 21208910 | Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. | Clin Infect Dis | 2011 | https://conductscience.org/library/papers/21208910 | PubMed |
| 8 | 32285851 | Antimicrobial resistance. Its importance and efforts to control it. | Gac Med Mex | 2020 | https://conductscience.org/library/papers/32285851 | PubMed |
| 9 | 17317057 | Uses and abuses of in vitro tests in ethnopharmacology: visualizing an elephant. | J Ethnopharmacol | 2007 | https://conductscience.org/library/papers/17317057 | PubMed |
| 10 | 17277059 | The transcriptional regulators NorG and MgrA modulate resistance to both quinolones and beta-lactams in Staphylococcus aureus. | J Bacteriol | 2007 | https://conductscience.org/library/papers/17277059 | PubMed |
| 11 | 19678712 | Efflux-mediated drug resistance in bacteria: an update. | Drugs | 2009 | https://conductscience.org/library/papers/19678712 | PubMed |
| 12 | 19399780 | AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. | J Comput Chem | 2009 | https://conductscience.org/library/papers/19399780 | PubMed |
| 13 | 26016486 | Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. | Clin Microbiol Rev | 2015 | https://conductscience.org/library/papers/26016486 | PubMed |
| 14 | 35361990 | Structural basis for inhibition of the drug efflux pump NorA from Staphylococcus aureus. | Nat Chem Biol | 2022 | https://conductscience.org/library/papers/35361990 | PubMed |
| 15 | 38503396 | Unlocking bacterial defense: Exploring the potent inhibition of NorA efflux pump by coumarin derivatives in Staphylococcus aureus. | Microb Pathog | 2024 | https://conductscience.org/library/papers/38503396 | PubMed |
| 16 | 33383131 | Aminophenyl chalcones potentiating antibiotic activity and inhibiting bacterial efflux pump. | Eur J Pharm Sci | 2021 | https://conductscience.org/library/papers/33383131 | PubMed |
| 17 | 27381291 | How to Measure Export via Bacterial Multidrug Resistance Efflux Pumps. | mBio | 2016 | https://conductscience.org/library/papers/27381291 | PubMed |
| 18 | 24576155 | Mechanism of quinolone action and resistance. | Biochemistry | 2014 | https://conductscience.org/library/papers/24576155 | PubMed |
| 19 | 20805405 | Origins and evolution of antibiotic resistance. | Microbiol Mol Biol Rev | 2010 | https://conductscience.org/library/papers/20805405 | PubMed |
| 20 | 30910733 | Dissection of Protonation Sites for Antibacterial Recognition and Transport in QacA, a Multi-Drug Efflux Transporter. | J Mol Biol | 2019 | https://conductscience.org/library/papers/30910733 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42650719 | In Vitro and In Silico Evaluation of the Potentiating Effect of Thiadiazine Derivatives Against Multidrug-Resistant (MDR) Bacterial Strains. | Antibiotics (Basel) | 2026 | https://conductscience.org/library/papers/42650719 | PubMed |
| 41697521 | Evaluation of the effects of hybrids of metronidazole and eugenol analogues as inhibitors of the Staphylococcus aureus NorA efflux pump: an in vitro and in silico analysis. | Folia Microbiol (Praha) | 2026 | https://conductscience.org/library/papers/41697521 | PubMed |
| 41465247 | Novel Mono-Substituted 4H-1,2,6-Thiadiazines with Antioxidant and Anti-Lipoxygenase Activities. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41465247 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39182011
GET https://conductscience.org/api/papers/v1/39182011/references?page=2